Midi Health is with women for the long haul.
What’s happening: The digital menopause care platform launched AgeWell, a diagnostics-led longevity program for women over 30.
Long live. Raising $85M in the past two years, Google-backed Midi Health is redefining women’s health. Extending beyond midlife care, Midi’s clinician-led platform now addresses life before, during, and after menopause.
AgeWell will layer bloodwork, genetic testing, DEXA scans, and full-body MRIs onto routine mammograms and Pap smears, enabling personalized prevention across heart, hormonal, brain, and muscle health, plus weight management and cancer prevention.
Why it matters: Insurance-backed and available nationwide, AgeWell lowers the barrier to longevity care while closing preventative medicine’s gender care gap.
Check mate. As Biograph, Neko, and Humanaut scale in-person longevity hubs, digital players like Function Health and Superpower are using diagnostics to expand access.
Others see longevity medicine as a standard telehealth offering, with Hone Health transitioning from TRT to vitality and Noom hiring Next Health’s medical director.
Looking ahead: Women deserve better than off-the-shelf care. As longevity goes mainstream, Midi’s life stage-specific model marks a new level of personalization.
